Plasma ofCS-modified CD44 predicts the survival of patients with lung cancer.
Wu ZY, Yang DW, He YQ, Wang TM, Zhou T, Li XZ, Zhang PF, Xue WQ, Zhang JB, Mu J, Jia WH.
Wu ZY, et al. Among authors: zhang pf, zhang jb.
Cancer Sci. 2024 Nov;115(11):3776-3787. doi: 10.1111/cas.16319. Epub 2024 Aug 27.
Cancer Sci. 2024.
PMID: 39192543
Free PMC article.